A Phase I Study of Oral BMS-275291, a Novel Nonhydroxamate Sheddase-Sparing Matrix Metalloproteinase Inhibitor, in Patients with Advanced or Metastatic Cancer
RIZVI, Naiyer A, HUMPHREY, Jeffrey S, HURWITZ, Herbert, NESS, Elizabeth A, JOHNSON, Michael D, GUPTA, Elora, WILLIAMS, Kathleen, DALY, Diana J, SONNICHSEN, Daryl, CONWAY, Delina, MARSHALL, John
Published in Clinical cancer research (15.03.2004)
Published in Clinical cancer research (15.03.2004)
Get full text
Journal Article
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group
Harvey, R Donald, Mileham, Kathryn F, Bhatnagar, Vishal, Brewer, Jamie R, Rahman, Atiqur, Moravek, Cassadie, Kennedy, Andrew S, Ness, Elizabeth A, Dees, E Claire, Ivy, S Percy, Ebbinghaus, Scot W, Schenkel, Caroline, Uldrick, Thomas S
Published in Clinical cancer research (01.05.2021)
Published in Clinical cancer research (01.05.2021)
Get full text
Journal Article
Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma
Frye, Robin, Myers, Mary, Axelrod, Karen C, Ness, Elizabeth A, Piekarz, Richard L, Bates, Susan E, Booher, Susan
Published in Clinical journal of oncology nursing (01.04.2012)
Published in Clinical journal of oncology nursing (01.04.2012)
Get full text
Journal Article